Clinical significance of extended-spectrum β-lactamases

Efficacy of Ertapenem for Consolidation Therapy of Extended-Spectrum β-lactamase-Producing Gram-Negative Infections: A Case Series Report

(2008) Melody L Berg et al.   ANNALS OF PHARMACOTHERAPY

Multiclonal Outbreak of Klebsiella pneumoniae Producing Extended-Spectrum  -Lactamase CTX-M-2 and Novel Variant CTX-M-59 in a Neonatal Intensive Care Unit in Brazil

(2008) D. de Oliveira Garcia et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Breakpoints for extended-spectrum β-lactamase-producing Enterobacteriacae: pharmacokinetic/pharmacodynamic considerations

(2008) A. MacGowan   CLINICAL MICROBIOLOGY AND INFECTION

Other antimicrobials of interest in the era of extended-spectrum β-lactamases: fosfomycin, nitrofurantoin and tigecycline

(2008) J. Garau   CLINICAL MICROBIOLOGY AND INFECTION

Minor extended-spectrum β-lactamases

(2008) T. Naas et al.   CLINICAL MICROBIOLOGY AND INFECTION

Comparative activity of meropenem in US medical centers (2007): initiating the 2nd decade of MYSTIC program surveillance

(2008) Ronald N. Jones et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Antimicrobial breakpoints for Gram-negative aerobic bacteria based on pharmacokinetic–pharmacodynamic models with Monte Carlo simulation

(2008) Christopher R. Frei et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Imported chicken meat as a potential source of quinolone-resistant Escherichia coli producing extended-spectrum  -lactamases in the UK

(2008) R. E. Warren et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Treatment of Recurrent Urosepsis with Tigecycline: a Pharmacological Perspective

(2008) D. Curcio   JOURNAL OF CLINICAL MICROBIOLOGY

Extended-spectrum β-lactamase (ESBL)-producing enterobacteria: factors associated with infection in the community setting, Auckland, New Zealand

(2008) C.T. Moor et al.   JOURNAL OF HOSPITAL INFECTION

The effect of control group selection in the analysis of risk factors for extended spectrum β-lactamase-producing Klebsiella pneumoniae infections. A prospective controlled study

(2008) P.R.P. Behar et al.   JOURNAL OF HOSPITAL INFECTION

Infections due to Escherichia coli producing extended-spectrum β-lactamase among hospitalised patients: factors influencing mortality

(2008) C. Peña et al.   JOURNAL OF HOSPITAL INFECTION

Use of tigecycline for the treatment of prolonged bacteremia due to a multiresistant VIM-1 and SHV-12 β-lactamase–producing Klebsiella pneumoniae epidemic clone

(2007) Javier Cobo et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Meropenem activity against European isolates: report on the MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) 2006 results

(2007) Philip J. Turner   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE